{
    "medicine_id": "c66c2caa1bc5e6f36d55e2baeb9654eb5bdac074",
    "platform_id": "DB09061",
    "metadata": {
        "name": "Cybid 10 33 33 mg 1mL Oil",
        "composition": "33 33 mg 1mL Cannabidiol",
        "clinical_particulars": {
            "therapeutic_indications": "When used in combination with delta 9 tetrahydrocannabinol as the product Sativex cannabidiol was given a standard marketing authorization ie a Notice of Compliance NOC by Health Canada for the following indications 1 as adjunctive treatment for symptomatic relief of spasticity in adult patients with multiple sclerosis MS who have not responded adequately to other therapy and who demonstrate meaningful improvement during an initial trial of therapy L886 Due to the need for confirmatory studies to verify the clinical benefit coupled with the promising nature of the clinical evidence Sativex was also given a Notice of Compliance with Conditions NOC c by Health Canada for the following indications 1 as adjunctive treatment for the symptomatic relief of neuropathic pain in adult patients with multiple sclerosis 2 as adjunctive analgesic treatment in adult patients with advanced cancer who experience moderate to severe pain during the highest tolerated dose of strong opioid therapy for persistent background pain L886",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Although the exact mechanism and magnitude of effects of THC and CBD are not fully understood CBD has been shown to have analgesic anticonvulsant muscle relaxant anxiolytic neuroprotective anti oxidant and anti psychotic activity This wide variety of effects is likely due to it s complex pharmacological mechanisms In addition to binding to CB1 and CB2 receptors of the endocannabinoid system there is evidence that CBD activates 5 HT1A serotonergic and TRPV1 2 vanilloid receptors antagonizes alpha 1 adrenergic and \u00b5 opioid receptors inhibits synaptosomal uptake of noradrenaline dopamine serotonin and gaminobutyric acid and cellular uptake of anandamide acts on mitochondria Ca2 stores blocks low voltage activated T type Ca2 channels stimulates activity of the inhibitory glycine receptor and inhibits activity of fatty amide hydrolase FAAH A31555 A31574",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00178",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Ramipril"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Remikiren"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Guanadrel"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Olmesartan"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Chlorthalidone"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Nitroprusside"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Minoxidil"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Fosinopril"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Trandolapril"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Metolazone"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Benazepril"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Candoxatril"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Mecamylamine"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Moexipril"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Lisinopril"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Nitroglycerin"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Cryptenamine"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Perindopril"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Fenoldopam"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Eprosartan"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Quinapril"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Telmisartan"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Methyldopa"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Deserpidine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Diazoxide"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Terazosin"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Captopril"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Polythiazide"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Cilazapril"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Saprisartan"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Spirapril"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Dexpropranolol"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Temocapril"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Trimazosin"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Nicorandil"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Imidapril"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Cannabidiol may decrease the antihypertensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Cicletanine"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Delapril"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Cyclopenthiazide"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Muzolimine"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Xipamide"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Furosemide"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Enalapril"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Isradipine"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Losartan"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Indapamide"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Irbesartan"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Guanethidine"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Hydralazine"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Pinacidil"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Macitentan"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Aliskiren"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Lacidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Niguldipine"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Selexipag"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Naftopidil"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Amlodipine"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "Cannabidiol may increase the central nervous system depressant CNS depressant activities of Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "Doxylamine may increase the central nervous system depressant CNS depressant activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Cannabidiol may increase the central nervous system depressant CNS depressant activities of Droperidol"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "Hydrocodone may increase the central nervous system depressant CNS depressant activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "Hydroxyzine may increase the central nervous system depressant CNS depressant activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Cannabidiol can be increased when used in combination with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Cannabidiol may increase the central nervous system depressant CNS depressant activities of Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Cannabidiol may increase the sedative activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Minocycline may increase the central nervous system depressant CNS depressant activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "Nabilone may increase the central nervous system depressant CNS depressant activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "Cannabidiol may increase the central nervous system depressant CNS depressant activities of Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "Cannabidiol may increase the central nervous system depressant CNS depressant activities of Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "Cannabidiol may increase the central nervous system depressant CNS depressant activities of Perampanel"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Cannabidiol may increase the sedative activities of Pramipexole"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "Cannabidiol may increase the sedative activities of Ropinirole"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Cannabidiol may increase the sedative activities of Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Rufinamide"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "Cannabidiol may increase the central nervous system depressant CNS depressant activities of Sodium oxybate"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "Cannabidiol may increase the central nervous system depressant CNS depressant activities of Suvorexant"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "Tapentadol may increase the central nervous system depressant CNS depressant activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Cannabidiol may increase the central nervous system depressant CNS depressant activities of Thalidomide"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "Cannabidiol may increase the central nervous system depressant CNS depressant activities of Zolpidem"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "The risk or severity of hypertension can be increased when Desmopressin is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of hypertension can be increased when Icosapent is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "The risk or severity of hypertension can be increased when Bethanidine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "The risk or severity of hypertension can be increased when Isoetharine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of hypertension can be increased when Mesalazine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of hypertension can be increased when Ketorolac is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of hypertension can be increased when Tolmetin is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00561",
                        "description": "The risk or severity of hypertension can be increased when Doxapram is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of hypertension can be increased when Fenoprofen is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of hypertension can be increased when Sulindac is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "The risk or severity of hypertension can be increased when Phentolamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "The risk or severity of hypertension can be increased when Tolazoline is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of hypertension can be increased when Carprofen is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of hypertension can be increased when Diflunisal is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of hypertension can be increased when Omapatrilat is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "The risk or severity of hypertension can be increased when Bitolterol is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "The risk or severity of hypertension can be increased when Phenoxybenzamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of hypertension can be increased when Oxaprozin is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of hypertension can be increased when Balsalazide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "The risk or severity of hypertension can be increased when Arbutamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of hypertension can be increased when Rescinnamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of hypertension can be increased when Olsalazine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "The risk or severity of hypertension can be increased when Pirbuterol is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of hypertension can be increased when Salsalate is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "The risk or severity of hypertension can be increased when Bambuterol is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of hypertension can be increased when Antrafenine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "The risk or severity of hypertension can be increased when Phendimetrazine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB02032",
                        "description": "The risk or severity of hypertension can be increased when Epicaptopril is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of hypertension can be increased when Taxifolin is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04581",
                        "description": "The risk or severity of hypertension can be increased when 1 benzylimidazole is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of hypertension can be increased when Benoxaprofen is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of hypertension can be increased when Cimicoxib is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "The risk or severity of hypertension can be increased when Amibegron is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "The risk or severity of hypertension can be increased when Solabegron is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The risk or severity of hypertension can be increased when Xylometazoline is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The risk or severity of hypertension can be increased when Isometheptene is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The risk or severity of hypertension can be increased when Levonordefrin is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The risk or severity of hypertension can be increased when Naphazoline is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "The risk or severity of hypertension can be increased when Saralasin is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of hypertension can be increased when Azapropazone is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of hypertension can be increased when Salicylamide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "The risk or severity of hypertension can be increased when Adrafinil is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of hypertension can be increased when Kebuzone is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of hypertension can be increased when Isoxicam is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "The risk or severity of hypertension can be increased when Indoramin is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of hypertension can be increased when Indoprofen is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of hypertension can be increased when Ibuproxam is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "The risk or severity of hypertension can be increased when Hexoprenaline is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of hypertension can be increased when Floctafenine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of hypertension can be increased when Fenbufen is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of hypertension can be increased when Etofenamate is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of hypertension can be increased when Epirizole is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Benzydamine"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Cirazoline"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Moxisylyte"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Dexibuprofen"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Dexketoprofen"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Droxicam"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Firocoxib"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Clonixin"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Moxonidine"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Morniflumate"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Talniflumate"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with DL Methylephedrine"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Amitraz"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Robenacoxib"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Tepoxalin"
                    },
                    {
                        "drugbank-id": "DB11481",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Atipamezole"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Flunixin"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Ractopamine"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Etafedrine"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with PF 00610355"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Abediterol"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Tulobuterol"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Dopexamine"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Nitroaspirin"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Indobufen"
                    },
                    {
                        "drugbank-id": "DB12551",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Idazoxan"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Ebselen"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Higenamine"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Reproterol"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Tinoridine"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Alclofenac"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Fentiazac"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Suxibuzone"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Octopamine"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Bumadizone"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Alminoprofen"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Difenpiramide"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Norfenefrine"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Oxyfedrine"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Nifenazone"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Lonazolac"
                    },
                    {
                        "drugbank-id": "DB13453",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Xenon"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Tenidap"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Buflomedil"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Propyphenazone"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Proglumetacin"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Guacetisal"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Ethenzamide"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Rimiterol"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Carbaspirin calcium"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Mofebutazone"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Proquazone"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Benorilate"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Pirprofen"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Xamoterol"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Acemetacin"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Imidazole salicylate"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Deoxyepinephrine"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with SC 236"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with NS 398"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Quinoline Yellow WS"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of hypertension can be increased when Ketoprofen is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of hypertension can be increased when Aceclofenac is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of hypertension can be increased when Salbutamol is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of hypertension can be increased when Nimesulide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The risk or severity of hypertension can be increased when Metamizole is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of hypertension can be increased when Zomepirac is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of hypertension can be increased when Indacaterol is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Tolfenamic acid"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Selpercatinib"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Loxoprofen"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "The risk or severity of hypertension can be increased when Cannabidiol is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "Cannabidiol may increase the hypertensive activities of Droxidopa"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Mefloquine"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The therapeutic efficacy of Mianserin can be decreased when used in combination with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01083",
                        "description": "Orlistat can cause a decrease in the absorption of Cannabidiol resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "Cannabidiol may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Methadone is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB01284",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Cannabidiol may increase the serotonergic activities of Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Cannabidiol may increase the central nervous system depressant CNS depressant activities of Ethanol"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "Cannabidiol may increase the central nervous system depressant CNS depressant activities of Azelastine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the central nervous system depressant CNS depressant activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Cannabidiol may increase the serotonergic activities of Methylene blue"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Trospium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Benzatropine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Disopyramide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Ipratropium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Metixene is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Buclizine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Trihexyphenidyl is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Oxyphencyclimine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Procyclidine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Profenamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Methscopolamine bromide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Tridihexethyl is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Anisotropine methylbromide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Atropine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Pirenzepine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Homatropine methylbromide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Benzquinamide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Propantheline is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Dicyclomine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Biperiden is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Methantheline is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Cycrimine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Tolterodine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Oxybutynin is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Flavoxate is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Diphenidol is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Tiotropium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Solifenacin is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Isopropamide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Mepenzolate is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Hexocyclium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Dimetindene is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Aclidinium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Dexetimide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Trimebutine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Imidafenacin is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Butylscopolamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Thonzylamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Methscopolamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Oxitropium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Propiverine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Batefenterol is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Mebeverine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Tropatepine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Prifinium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Piperidolate is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Benzilone is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Difemerine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Phenglutarimide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Mazaticol is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Etybenzatropine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Otilonium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Poldine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Bevonium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Rociverine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Bornaprine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Etanautine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Tiemonium iodide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Dihexyverine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Penthienate is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Diphemanil is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Camylofin is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Fenpiverinium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Emetonium iodide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Pipenzolate is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Timepidium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Quinidine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "The risk or severity of Tachycardia and drowsiness can be increased when Chlorphenoxamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Midodrine"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Norepinephrine"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Phenylephrine"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Metaraminol"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Methoxamine"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Orciprenaline"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Phenmetrazine"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Dobutamine"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Ritodrine"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Terbutaline"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Oxymetazoline"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Dopamine"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Isoprenaline"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Fenoterol"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Ephedrine"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Procaterol"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Clenbuterol"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Tetryzoline"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Tyramine"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Isoxsuprine"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Etilefrine"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Synephrine"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Racepinephrine"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Tramazoline"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Fenozolone"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Tretoquinol"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Prenalterol"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Mefenorex"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Methylenedioxyethamphetamine"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Nylidrin"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Troglitazone"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Sulfinpyrazone"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Floxuridine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Miconazole"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB06729",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Sulfaphenazole"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "Methylergometrine may increase the vasoconstricting activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "Nicergoline may increase the vasoconstricting activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "Dihydroergocornine may increase the vasoconstricting activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "Dihydroergocristine may increase the vasoconstricting activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "Dihydroergocryptine may increase the vasoconstricting activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "Terguride may increase the vasoconstricting activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The therapeutic efficacy of Cannabidiol can be increased when used in combination with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB00201",
                        "description": "Cannabidiol may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "Cannabidiol may increase the excretion rate of Dyphylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "Cannabidiol may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "Cannabidiol may increase the excretion rate of Mercaptopurine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01303",
                        "description": "Cannabidiol may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "Cannabidiol may increase the excretion rate of Theobromine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01482",
                        "description": "Cannabidiol may increase the excretion rate of Fenethylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01667",
                        "description": "Cannabidiol may increase the excretion rate of 8 azaguanine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01978",
                        "description": "Cannabidiol may increase the excretion rate of 7 9 Dimethylguanine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB02134",
                        "description": "Cannabidiol may increase the excretion rate of Xanthine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB02245",
                        "description": "Cannabidiol may increase the excretion rate of 7 Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB02377",
                        "description": "Cannabidiol may increase the excretion rate of Guanine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB02489",
                        "description": "Cannabidiol may increase the excretion rate of 9 Methylguanine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB02568",
                        "description": "Cannabidiol may increase the excretion rate of Peldesine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04076",
                        "description": "Cannabidiol may increase the excretion rate of Hypoxanthine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04356",
                        "description": "Cannabidiol may increase the excretion rate of 9 Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06479",
                        "description": "Cannabidiol may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06575",
                        "description": "Cannabidiol may increase the excretion rate of Valomaciclovir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB07954",
                        "description": "Cannabidiol may increase the excretion rate of 3 isobutyl 1 methyl 7H xanthine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08844",
                        "description": "Cannabidiol may increase the excretion rate of Uric acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "Cannabidiol may increase the excretion rate of Doxofylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11919",
                        "description": "Cannabidiol may increase the excretion rate of 6 O benzylguanine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12406",
                        "description": "Cannabidiol may increase the excretion rate of Lisofylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12531",
                        "description": "Cannabidiol may increase the excretion rate of Lobucavir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12926",
                        "description": "Cannabidiol may increase the excretion rate of Cafedrine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "Cannabidiol may increase the excretion rate of Theodrenaline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13203",
                        "description": "Cannabidiol may increase the excretion rate of Bamifylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13449",
                        "description": "Cannabidiol may increase the excretion rate of Proxyphylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13573",
                        "description": "Cannabidiol may increase the excretion rate of Acefylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13592",
                        "description": "Cannabidiol may increase the excretion rate of Etamiphylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13634",
                        "description": "Cannabidiol may increase the excretion rate of Pentifylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13812",
                        "description": "Cannabidiol may increase the excretion rate of Bufylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "Cannabidiol may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14029",
                        "description": "Cannabidiol may increase the excretion rate of Furafylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14132",
                        "description": "Cannabidiol may increase the excretion rate of 8 chlorotheophylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB15122",
                        "description": "Cannabidiol may increase the excretion rate of PCS 499 which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Cannabidiol can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Cannabidiol can be increased when used in combination with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "Cannabidiol may decrease the excretion rate of Folic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "Cannabidiol may decrease the excretion rate of Pravastatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "Cannabidiol may decrease the excretion rate of Cladribine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Cannabidiol may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "Cannabidiol may decrease the excretion rate of Gefitinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "Cannabidiol may decrease the excretion rate of Allopurinol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "Cannabidiol may decrease the excretion rate of Cerivastatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "Cannabidiol may decrease the excretion rate of Prazosin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00481",
                        "description": "Cannabidiol may decrease the excretion rate of Raloxifene which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "Cannabidiol may decrease the excretion rate of Celecoxib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "Cannabidiol may decrease the excretion rate of Zidovudine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "Cannabidiol may decrease the excretion rate of Oxaliplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "Cannabidiol may decrease the excretion rate of Methotrexate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00602",
                        "description": "Cannabidiol may decrease the excretion rate of Ivermectin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Cannabidiol may decrease the excretion rate of Testosterone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "Cannabidiol may decrease the excretion rate of Clofarabine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Cannabidiol may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "Cannabidiol may decrease the excretion rate of Daunorubicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Cannabidiol may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "Cannabidiol may decrease the excretion rate of Lamivudine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "Cannabidiol may decrease the excretion rate of Irinotecan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "Cannabidiol may decrease the excretion rate of Sulfasalazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "Cannabidiol may decrease the excretion rate of Dactinomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00973",
                        "description": "Cannabidiol may decrease the excretion rate of Ezetimibe which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "Cannabidiol may decrease the excretion rate of Doxorubicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "Cannabidiol may decrease the excretion rate of Glyburide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "Cannabidiol may decrease the excretion rate of Tegaserod which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "Cannabidiol may decrease the excretion rate of Leflunomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "Cannabidiol may decrease the excretion rate of Rosuvastatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "Cannabidiol may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03496",
                        "description": "Cannabidiol may decrease the excretion rate of Alvocidib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04690",
                        "description": "Cannabidiol may decrease the excretion rate of Camptothecin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "Cannabidiol may decrease the excretion rate of Simeprevir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "Cannabidiol may decrease the excretion rate of Pazopanib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "Cannabidiol may decrease the excretion rate of Apixaban which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08860",
                        "description": "Cannabidiol may decrease the excretion rate of Pitavastatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "Cannabidiol may decrease the excretion rate of Teriflunomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "Cannabidiol may decrease the excretion rate of Vemurafenib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "Cannabidiol may decrease the excretion rate of Afatinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "Cannabidiol may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Cannabidiol may decrease the excretion rate of Riociguat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "Cannabidiol may decrease the excretion rate of Sofosbuvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "Cannabidiol may decrease the excretion rate of Palbociclib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "Cannabidiol may decrease the excretion rate of Lenvatinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09279",
                        "description": "Cannabidiol may decrease the excretion rate of Fimasartan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "Cannabidiol may decrease the excretion rate of Ombitasvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "Cannabidiol may decrease the excretion rate of Tenofovir alafenamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "Cannabidiol may decrease the excretion rate of Osimertinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "Cannabidiol may decrease the excretion rate of Venetoclax which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "Cannabidiol may decrease the excretion rate of Velpatasvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11760",
                        "description": "Cannabidiol may decrease the excretion rate of Talazoparib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "Cannabidiol may decrease the excretion rate of Ertugliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "Cannabidiol may decrease the excretion rate of Revefenacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "Cannabidiol may decrease the excretion rate of Delafloxacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "Cannabidiol may decrease the excretion rate of Duvelisib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "Cannabidiol may decrease the excretion rate of Glasdegib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "Cannabidiol may decrease the excretion rate of Abemaciclib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "Cannabidiol may decrease the excretion rate of Voxilaprevir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "Cannabidiol may decrease the excretion rate of Brigatinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "Cannabidiol may decrease the excretion rate of Rucaparib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13125",
                        "description": "Cannabidiol may decrease the excretion rate of Lusutrombopag which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "Cannabidiol may decrease the excretion rate of Pibrentasvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "Cannabidiol may decrease the excretion rate of Glecaprevir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Cannabidiol may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "Cannabidiol may decrease the excretion rate of Darolutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "Cannabidiol may decrease the excretion rate of Tazemetostat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "Cannabidiol may decrease the excretion rate of Selumetinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "Cannabidiol may decrease the excretion rate of Pralatrexate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "Cannabidiol may decrease the excretion rate of Idelalisib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "Cannabidiol may decrease the excretion rate of Ripretinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "Cannabidiol may decrease the excretion rate of Fostemsavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "Cannabidiol may decrease the excretion rate of Pralsetinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB08873",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Boceprevir"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB13179",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Troleandomycin"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Voriconazole"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00250",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Dapsone"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Lidocaine"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Flutamide"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Propranolol"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Nateglinide"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Tretinoin"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Disulfiram"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Salmeterol"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Nitrendipine"
                    },
                    {
                        "drugbank-id": "DB01058",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Praziquantel"
                    },
                    {
                        "drugbank-id": "DB01103",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Quinacrine"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Cilostazol"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Finasteride"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06267",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Udenafil"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Saxagliptin"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06652",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Vicriviroc"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ivacaftor"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "The metabolism of Daclatasvir can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The metabolism of Paritaprevir can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The metabolism of Tezacaftor can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11737",
                        "description": "The metabolism of Icotinib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "The metabolism of Valbenazine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The metabolism of Deutetrabenazine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12301",
                        "description": "The metabolism of Doravirine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB14541",
                        "description": "The metabolism of Hydrocortisone cypionate can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Istradefylline can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Dutasteride"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The metabolism of Pentamidine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04856",
                        "description": "The metabolism of Dexloxiglumide can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The metabolism of Azimilide can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12130",
                        "description": "The metabolism of Lorlatinib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00673",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Aprepitant"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB02520",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ditiocarb"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The metabolism of Sildenafil can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The metabolism of Indinavir can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Lovastatin can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Nevirapine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The metabolism of Terfenadine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "The metabolism of Nisoldipine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The metabolism of Buspirone can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The metabolism of Triamcinolone can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The metabolism of Simvastatin can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "The metabolism of Eplerenone can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Amprenavir can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The metabolism of Hydrocortisone can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "The metabolism of Tadalafil can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The metabolism of Vardenafil can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The metabolism of Felodipine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The metabolism of Telaprevir can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The metabolism of Rivaroxaban can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06419",
                        "description": "The metabolism of Cethromycin can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The metabolism of Artemether can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The metabolism of Enzalutamide can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The metabolism of Benidipine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The metabolism of Elbasvir can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Asunaprevir can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The metabolism of Fluticasone can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "The metabolism of Estradiol acetate can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "The metabolism of Estradiol dienanthate can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The metabolism of Hydrocortisone acetate can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB15444",
                        "description": "The metabolism of Elexacaftor can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Letermovir"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "The metabolism of Levamlodipine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The metabolism of Atorvastatin can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "The metabolism of Clindamycin can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Clofazimine"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The metabolism of Hydrocortisone butyrate can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "The metabolism of Estrone can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB14542",
                        "description": "The metabolism of Hydrocortisone phosphate can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The metabolism of Teniposide can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The metabolism of Vincristine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The metabolism of Etoposide can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The metabolism of Copanlisib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Axitinib"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The metabolism of Olaparib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "The metabolism of Tegafur can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Erlotinib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Cyclophosphamide can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Astemizole can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Ifosfamide can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The metabolism of Docetaxel can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The metabolism of Dasatinib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The metabolism of Sunitinib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The metabolism of Trastuzumab emtansine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11703",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Acalabrutinib"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB00745",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Modafinil"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Budesonide"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Beclomethasone dipropionate"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Paramethasone"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Fluprednidene"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Meprednisone"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Deflazacort"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Prednylidene"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Cloprednol"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Prednisolone phosphate"
                    },
                    {
                        "drugbank-id": "DB14633",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Prednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Methylprednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Prednisone acetate"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Clocortolone acetate"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Melengestrol acetate"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Betamethasone phosphate"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Cortisone"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Clobetasol propionate"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Fluocinonide"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Mometasone"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Fluocortolone"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Clobetasol"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The metabolism of Tacrolimus can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The metabolism of Sirolimus can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The metabolism of Paclitaxel can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The metabolism of Esmolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The metabolism of Betaxolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Metoprolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "The metabolism of Atenolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The metabolism of Timolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "The metabolism of Nadolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The metabolism of Bevantolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "The metabolism of Practolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "The metabolism of Debrisoquine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The metabolism of Indenolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The metabolism of Talinolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "The metabolism of Landiolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The metabolism of Esatenolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "The metabolism of Cloranolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The metabolism of Anisodamine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The metabolism of Labetalol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The metabolism of Acebutolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The metabolism of Celiprolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The metabolism of Bucindolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The metabolism of Epanolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Formoterol"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Idarubicin"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Arformoterol"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Dapagliflozin"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Propacetamol"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Cevimeline"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ticlopidine"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Bupivacaine"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Mexiletine"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Galantamine"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Tamsulosin"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Perhexiline"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Aminophenazone"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Antipyrine"
                    },
                    {
                        "drugbank-id": "DB03783",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Phenacetin"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Nebivolol"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Alogliptin"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Dasabuvir can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "The metabolism of Lorpiprazole can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The metabolism of Rupatadine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The metabolism of Ipecac can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Nicotine"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ciclesonide"
                    },
                    {
                        "drugbank-id": "DB00592",
                        "description": "The metabolism of Piperazine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "The metabolism of Phenformin can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The metabolism of Encainide can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "The metabolism of Aprindine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The metabolism of Tetrabenazine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04889",
                        "description": "The metabolism of Bicifadine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06506",
                        "description": "The metabolism of Repinotan can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06608",
                        "description": "The metabolism of Tafenoquine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The metabolism of Bufuralol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "The metabolism of Sparteine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06735",
                        "description": "The metabolism of Enclomiphene can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "The metabolism of Bopindolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09173",
                        "description": "The metabolism of Butyrfentanyl can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The metabolism of Arotinolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The metabolism of Levobetaxolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The metabolism of Elagolix can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "The metabolism of Mepindolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "The metabolism of Tertatolol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Acetaminophen can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The metabolism of Darifenacin can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The metabolism of Loperamide can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Tipranavir can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The metabolism of Mequitazine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The metabolism of Fusidic acid can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Tesmilifene can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The metabolism of Eliglustat can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The metabolism of Bortezomib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The metabolism of Encorafenib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Enasidenib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Flecainide"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The metabolism of Sotalol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The metabolism of Procainamide can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "The metabolism of Dihydralazine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Nabumetone"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Guanabenz"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The metabolism of R warfarin can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Naproxen"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ranitidine"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ropivacaine"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00518",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Albendazole"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Diclofenac"
                    },
                    {
                        "drugbank-id": "DB00744",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Zileuton"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Levobupivacaine"
                    },
                    {
                        "drugbank-id": "DB01012",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Cinacalcet"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The metabolism of Carmustine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "The metabolism of Tacrine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "The metabolism of Triamterene can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00442",
                        "description": "The metabolism of Entecavir can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The metabolism of Pemetrexed can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00730",
                        "description": "The metabolism of Thiabendazole can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "The metabolism of Acyclovir can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The metabolism of Lomefloxacin can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The metabolism of Azathioprine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01056",
                        "description": "The metabolism of Tocainide can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01094",
                        "description": "The metabolism of Hesperetin can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The metabolism of Temafloxacin can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04951",
                        "description": "The metabolism of Pirfenidone can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB05708",
                        "description": "The metabolism of GTS 21 can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Eltrombopag can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06235",
                        "description": "The metabolism of Vadimezan can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The metabolism of Binimetinib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The metabolism of Rofecoxib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Terbinafine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The metabolism of Primaquine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The metabolism of Resveratrol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06774",
                        "description": "The metabolism of Capsaicin can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00299",
                        "description": "The metabolism of Penciclovir can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The metabolism of Fluorouracil can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The metabolism of Dacarbazine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The metabolism of Bendamustine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The metabolism of Aminophylline can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Bosentan"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Avatrombopag"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "The metabolism of Tienilic acid can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Valsartan"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Torasemide"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Sulfadiazine"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Cisplatin"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Zafirlukast"
                    },
                    {
                        "drugbank-id": "DB00576",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Sulfamethizole"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Amodiaquine"
                    },
                    {
                        "drugbank-id": "DB00621",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Oxandrolone"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Nilutamide"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Epinephrine"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Clopidogrel"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Phenylbutazone"
                    },
                    {
                        "drugbank-id": "DB00891",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Sulfapyridine"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Metronidazole"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Isoniazid"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Sulfamethoxazole"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Fenofibrate"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Fluvastatin"
                    },
                    {
                        "drugbank-id": "DB01117",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Atovaquone"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ginkgo biloba"
                    },
                    {
                        "drugbank-id": "DB01411",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Pranlukast"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Etoricoxib"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Genistein"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Topiroxostat"
                    },
                    {
                        "drugbank-id": "DB03756",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Doconexent"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Clevidipine"
                    },
                    {
                        "drugbank-id": "DB06150",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Sulfadimethoxine"
                    },
                    {
                        "drugbank-id": "DB06174",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Noscapine"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06413",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Armodafinil"
                    },
                    {
                        "drugbank-id": "DB06442",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Avasimibe"
                    },
                    {
                        "drugbank-id": "DB08798",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Sulfamoxole"
                    },
                    {
                        "drugbank-id": "DB08828",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Vismodegib"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Lobeglitazone"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB11994",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Diacerein"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB12319",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Benzbromarone"
                    },
                    {
                        "drugbank-id": "DB13975",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Black cohosh"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Probenecid"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB06414",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Etravirine"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Atazanavir"
                    },
                    {
                        "drugbank-id": "DB13174",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Rhein"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Candesartan"
                    },
                    {
                        "drugbank-id": "DB14033",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Acetyl sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Valdecoxib"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB04911",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Oritavancin"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Glimepiride"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Indomethacin"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Treprostinil"
                    },
                    {
                        "drugbank-id": "DB00414",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Acetohexamide"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Tenoxicam"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Piroxicam"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Chlorpropamide"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Flurbiprofen"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Etodolac"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Mefenamic acid"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Tolazamide"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Salicylic acid"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Acetylsalicylic acid"
                    },
                    {
                        "drugbank-id": "DB01120",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Gliclazide"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Tolbutamide"
                    },
                    {
                        "drugbank-id": "DB01131",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Proguanil"
                    },
                    {
                        "drugbank-id": "DB01251",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Gliquidone"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Lumiracoxib"
                    },
                    {
                        "drugbank-id": "DB01289",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Glisoxepide"
                    },
                    {
                        "drugbank-id": "DB04557",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Arachidonic Acid"
                    },
                    {
                        "drugbank-id": "DB04725",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Licofelone"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ximelagatran"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Prasugrel"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Lornoxicam"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Zaltoprofen"
                    },
                    {
                        "drugbank-id": "DB06803",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Niclosamide"
                    },
                    {
                        "drugbank-id": "DB08962",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Glibornuride"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The metabolism of Olodaterol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "The metabolism of Lesinurad can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13406",
                        "description": "The metabolism of Carbutamide can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13675",
                        "description": "The metabolism of Metahexamide can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Glipizide"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Trimethoprim"
                    },
                    {
                        "drugbank-id": "DB00471",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Montelukast"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Meloxicam"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ibuprofen"
                    },
                    {
                        "drugbank-id": "DB04938",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Ospemifene"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Indisulam"
                    },
                    {
                        "drugbank-id": "DB06739",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Seratrodast"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Tranilast"
                    },
                    {
                        "drugbank-id": "DB13941",
                        "description": "The metabolism of Piperaquine can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The metabolism of S Warfarin can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB14975",
                        "description": "The metabolism of Voxelotor can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Parecoxib"
                    },
                    {
                        "drugbank-id": "DB15233",
                        "description": "The metabolism of Avapritinib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Tamoxifen can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Dacomitinib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Capecitabine"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The metabolism of Dicoumarol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The metabolism of Phenprocoumon can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The metabolism of Acenocoumarol can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The metabolism of Fluindione can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The metabolism of Warfarin can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08875",
                        "description": "The metabolism of Cannabidiol can be decreased when combined with Cabozantinib"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The metabolism of Erdafitinib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The metabolism of Siponimod can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of adverse effects can be increased when Rimonabant is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06624",
                        "description": "The risk or severity of adverse effects can be increased when Taranabant is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Botulinum Toxin Type B"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Botulinum toxin type A"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tryptophan"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Baclofen"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Amphetamine"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lorazepam"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ethchlorvynol"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Succinylcholine"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Eletriptan"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Enflurane"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Temazepam"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Reboxetine"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butabarbital"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butalbital"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methysergide"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cabergoline"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Topiramate"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Venlafaxine"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Atomoxetine"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Etomidate"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Morphine"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Talbutal"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pentobarbital"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Codeine"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tolcapone"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hydromorphone"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Olanzapine"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cetirizine"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Protriptyline"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Trimethadione"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Chlorzoxazone"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Meprobamate"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thiethylperazine"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Palonosetron"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alprazolam"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dexbrompheniramine"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Loxapine"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Remoxipride"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Metocurine iodide"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Secobarbital"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methocarbamol"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Triprolidine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cyproheptadine"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Meperidine"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Metharbital"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methohexital"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Chlordiazepoxide"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gallamine triethiodide"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Entacapone"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxycodone"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Triflupromazine"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dextromethorphan"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mephenytoin"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Amoxapine"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Adinazolam"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lamotrigine"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cisatracurium"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mazindol"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fluticasone propionate"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lisuride"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ethosuximide"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thiopental"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butorphanol"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Furazolidone"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Paramethadione"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fluphenazine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clorazepic acid"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dexmedetomidine"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dyclonine"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dextropropoxyphene"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pentazocine"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Metaxalone"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Trimethobenzamide"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Sumatriptan"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Moricizine"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Midazolam"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Flurazepam"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ergotamine"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tizanidine"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Sufentanil"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Apomorphine"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Procaine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Rocuronium"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Atracurium besylate"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Risperidone"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Meclizine"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Riluzole"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Scopolamine"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Isoflurane"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ethotoin"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clidinium"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxcarbazepine"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Propiomazine"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Halazepam"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alfentanil"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Minaprine"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fentanyl"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Propofol"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Acetazolamide"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Diazepam"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Trifluoperazine"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phensuximide"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brompheniramine"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Progabide"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxazepam"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Donepezil"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methylphenobarbital"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Perphenazine"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Levorphanol"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benzphetamine"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alprenolol"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Triazolam"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Remifentanil"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tiagabine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Almotriptan"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Diethylpropion"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hexafluronium"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Felbamate"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Naratriptan"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Rizatriptan"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pindolol"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zaleplon"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alosetron"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ramelteon"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gabapentin"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Frovatriptan"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Guanfacine"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methoxyflurane"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Selegiline"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Acetophenazine"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Melatonin"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clonazepam"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Promethazine"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vigabatrin"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Diphenoxylate"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Levocabastine"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methyprylon"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenacemide"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Doxacurium"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Doxepin"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Desipramine"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thiamylal"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bupropion"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Halothane"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Procarbazine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cyclizine"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Chlormezanone"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pergolide"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Desflurane"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxymorphone"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zopiclone"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tubocurarine"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Levetiracetam"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dezocine"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Estazolam"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dantrolene"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ketamine"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mivacurium"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Levodopa"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Sevoflurane"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Aripiprazole"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Chlorprothixene"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Decamethonium"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alimemazine"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Isocarboxazid"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ergometrine"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Metocurine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pancuronium"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pipecuronium"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vecuronium"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Amobarbital"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Aprobarbital"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butobarbital"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Heptabarbital"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hexobarbital"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Penbutolol"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Rasagiline"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Yohimbine"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methadyl acetate"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Glutethimide"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with gamma Hydroxybutyric acid"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with MMDA"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bufotenine"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dihydroetorphine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Diamorphine"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Midomafetamine"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fencamfamin"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with 4 Methoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Barbital"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with 4 Bromo 2 5 dimethoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Camazepam"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dichloralphenazone"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Etorphine"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Difenoxin"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tenamfetamine"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Delorazepam"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dextromoramide"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Desomorphine"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Chlorhexadol"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Carfentanil"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ethyl loflazepate"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Drotebanol"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cloxazolam"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alphacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bromazepam"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clotiazepam"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cathinone"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dihydromorphine"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fludiazepam"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Metamfetamine"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ketazolam"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Prazepam"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Quazepam"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cinolazepam"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nitrazepam"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Periciazine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alverine"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Molindone"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thiothixene"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pargyline"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Rolipram"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with 7 Nitroindazole"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with S Ethylisothiourea"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Domoic Acid"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxitriptan"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phencyclidine"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clorgiline"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Valpromide"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenethylamine"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Aniracetam"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methapyrilene"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nialamide"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nomifensine"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Urethane"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lysergic acid diethylamide"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methaqualone"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Amineptine"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Flunarizine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lorcaserin"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Osanetant"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cilansetron"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bifeprunox"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pagoclone"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Renzapride"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ezogabine"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with APD791"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tetrodotoxin"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methsuximide"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pimavanserin"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brivaracetam"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Naronapride"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Naluzotan"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with PRX 08066"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with BL 1020"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gantacurium"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lumateperone"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with YKP 1358"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Sertindole"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lacosamide"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tolperisone"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Remacemide"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clomethiazole"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Deramciclane"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tramiprosate"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ocinaplon"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gaboxadol"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Adipiplon"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dextofisopam"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Agomelatine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Saredutant"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Esmirtazapine"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vilazodone"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nitrous oxide"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dexmethylphenidate"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fospropofol"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Triclofos"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benzyl alcohol"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mebutamate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Sulthiame"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cinitapride"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tofisopam"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Serotonin"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with DPDPE"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gabapentin enacarbil"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Arbaclofen Placarbil"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Perospirone"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Amperozide"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ifenprodil"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Etifoxine"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dimetacrine"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Beclamide"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Captodiame"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brotizolam"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benzoctamine"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tasimelteon"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Eslicarbazepine acetate"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Etizolam"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dosulepin"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Edivoxetine"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Viloxazine"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nisoxetine"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lortalamine"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Talopram"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Etoperidone"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Blonanserin"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zotepine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brilaroxazine"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Iproclozide"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ramosetron"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxaprotiline"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Opium"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pyrantel"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alfaxalone"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Azaperone"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Doramectin"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Romifidine"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tiletamine"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tricaine"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zolazepam"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Detomidine"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thiocolchicoside"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Normethadone"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Psilocybin"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mosapride"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Iferanserin"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tropisetron"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brexanolone"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Etiracetam"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lanicemine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Idalopirdine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Imagabalin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Eplivanserin"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cerlapirdine"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Eltanolone"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Salvinorin A"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Carisbamate"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Esreboxetine"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bromperidol"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Orvepitant"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Piritramide"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Raclopride"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benzodiazepine"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with AZD 3043"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Indiplon"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Urapidil"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Perazine"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benperidol"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Opipramol"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pivagabine"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Prothipendyl"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Neosaxitoxin"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tiapride"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nefiracetam"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Valnoctamide"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Medifoxamine"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Apronalide"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Propanidid"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Proxibarbal"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Atracurium"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Febarbamate"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tetrazepam"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pyrithyldione"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Deanol"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenprobamate"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Styramate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pheneturide"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bromisoval"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vinbarbital"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Neocitrullamon"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Acetylglycinamide chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fenyramidol"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxaflozane"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Metergoline"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mebicar"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Veralipride"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gedocarnil"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Iprazochrome"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Emylcamate"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Allobarbital"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gallamine"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Naftidrofuryl"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxiracetam"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fabomotizole"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pridinol"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alcuronium"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Hexapropymate"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mosapramine"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Niaprazine"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vinyl ether"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Methylpentynol"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cyclobarbital"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fazadinium bromide"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mephenoxalone"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vinylbital"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tilidine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ethadione"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Reposal"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Carbromal"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Doxefazepam"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lormetazepam"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brofaromine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cyclopropane"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with MRK 409"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cannabidivarin"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lithium carbonate"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxazepam acetate"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cinazepam"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pyrazolam"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bentazepam"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of adverse effects can be increased when GW842166 is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of adverse effects can be increased when Ibipinabant is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of adverse effects can be increased when Surinabant is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of adverse effects can be increased when WIN 55212 2 is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of adverse effects can be increased when Nabiximols is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of adverse effects can be increased when Palmidrol is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB14737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabinol is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lemborexant"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Remimazolam"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The risk or severity of serotonin syndrome can be increased when Lisdexamfetamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The risk or severity of serotonin syndrome can be increased when Mephentermine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01459",
                        "description": "The risk or severity of serotonin syndrome can be increased when Bezitramide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The risk or severity of serotonin syndrome can be increased when 2 5 Dimethoxy 4 ethylamphetamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The risk or severity of serotonin syndrome can be increased when Chlorphentermine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dextroamphetamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB08167",
                        "description": "The risk or severity of serotonin syndrome can be increased when Methylthioninium is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Eluxadoline"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13910",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Valproate bismuth"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Methylphenidate"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Chlorambucil"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Cefalotin"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Cefotaxime"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00902",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Methdilazine"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Ganciclovir"
                    },
                    {
                        "drugbank-id": "DB01061",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Azlocillin"
                    },
                    {
                        "drugbank-id": "DB01598",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Imipenem"
                    },
                    {
                        "drugbank-id": "DB01610",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Valganciclovir"
                    },
                    {
                        "drugbank-id": "DB02136",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Cephalosporin analog"
                    },
                    {
                        "drugbank-id": "DB03313",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Cephalosporin C"
                    },
                    {
                        "drugbank-id": "DB03938",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Deacetoxycephalosporin C"
                    },
                    {
                        "drugbank-id": "DB06793",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Levopropoxyphene"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Sodium phosphate monobasic"
                    },
                    {
                        "drugbank-id": "DB11199",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Sage oil"
                    },
                    {
                        "drugbank-id": "DB11238",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Borage oil"
                    },
                    {
                        "drugbank-id": "DB11358",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Evening primrose oil"
                    },
                    {
                        "drugbank-id": "DB11447",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Phenothiazine"
                    },
                    {
                        "drugbank-id": "DB13854",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Gamolenic acid"
                    },
                    {
                        "drugbank-id": "DB14071",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Desmethylsertraline"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Azatadine"
                    },
                    {
                        "drugbank-id": "DB01362",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Iohexol"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Amphotericin B"
                    },
                    {
                        "drugbank-id": "DB14256",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Centella asiatica"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of Tachycardia can be increased when Adenosine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "The risk or severity of Tachycardia can be increased when Protokylol is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of hypertension can be increased when Esketamine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of adverse effects can be increased when Carisoprodol is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of hypertension can be increased when Solriamfetol is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may increase the hypertensive activities of Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The serum concentration of Alpelisib can be increased when it is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of CNS depression can be increased when Cannabidiol is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "Cannabidiol may increase the Change in thyroid function activities of Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of sedation can be increased when Clonidine is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "The metabolism of Testosterone enanthate can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Diethylstilbestrol"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Progesterone"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Medroxyprogesterone acetate"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Estrone sulfate"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Estradiol"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Estradiol benzoate"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Estradiol cypionate"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Estradiol valerate"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Etonogestrel"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Desogestrel"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Megestrol acetate"
                    },
                    {
                        "drugbank-id": "DB00367",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Levonorgestrel"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Norethisterone"
                    },
                    {
                        "drugbank-id": "DB00823",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Ethynodiol diacetate"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Ethinylestradiol"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Mestranol"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Cyproterone acetate"
                    },
                    {
                        "drugbank-id": "DB06713",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Norelgestromin"
                    },
                    {
                        "drugbank-id": "DB06730",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Gestodene"
                    },
                    {
                        "drugbank-id": "DB06789",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Hydroxyprogesterone caproate"
                    },
                    {
                        "drugbank-id": "DB08867",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Ulipristal"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "The metabolism of Dienogest can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09371",
                        "description": "The metabolism of Norethynodrel can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09389",
                        "description": "The metabolism of Norgestrel can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11619",
                        "description": "The metabolism of Gestrinone can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11636",
                        "description": "The metabolism of Nomegestrol can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12474",
                        "description": "The metabolism of Lynestrenol can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13528",
                        "description": "The metabolism of Chlormadinone can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13685",
                        "description": "The metabolism of Quingestanol can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13857",
                        "description": "The metabolism of Demegestone can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13866",
                        "description": "The metabolism of Etynodiol can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13981",
                        "description": "The metabolism of Nomegestrol acetate can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The metabolism of Cannabidiol can be increased when combined with Drospirenone"
                    },
                    {
                        "drugbank-id": "DB04066",
                        "description": "The metabolism of p Coumaric acid can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB04682",
                        "description": "The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB05830",
                        "description": "The metabolism of Trestolone can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06266",
                        "description": "The metabolism of Lonidamine can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB06804",
                        "description": "The metabolism of Nonoxynol 9 can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "The metabolism of Isosorbide can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB11507",
                        "description": "The metabolism of Cloprostenol can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB12025",
                        "description": "The metabolism of Triptolide can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13044",
                        "description": "The metabolism of Gossypol can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13310",
                        "description": "The metabolism of Ormeloxifene can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB13563",
                        "description": "The metabolism of Norgestrienone can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB14583",
                        "description": "The metabolism of Segesterone acetate can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB14678",
                        "description": "The metabolism of Norethindrone enanthate can be increased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of CNS depression can be increased when Cannabidiol is combined with Cyclobenzaprine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of sedation can be increased when Metoclopramide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Cannabidiol can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB15328",
                        "description": "The serum concentration of Ubrogepant can be increased when it is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Tramadol"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB12457",
                        "description": "The serum concentration of Rimegepant can be increased when it is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Cannabidiol can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of CNS depression can be increased when Cannabidiol is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB12612",
                        "description": "Cannabidiol may decrease the excretion rate of Ozanimod which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of vasospastic reactions can be increased when Cannabidiol is combined with Zolmitriptan"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of CNS depression can be increased when Cannabidiol is combined with Ziconotide"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Fenfluramine"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Cannabidiol can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of hypotension sedation death somnolence and respiratory depression can be increased when Cannabidiol is combined with Oliceridine"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Cannabidiol can be decreased when it is combined with Satralizumab"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The serum concentration of Berotralstat can be increased when it is combined with Cannabidiol"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}